This study highlighted the significant associations between PD-MCI and several factors, including triglycerides (TG), apolipoprotein A1 (ApoA1), and the SNCA rs6826785 genetic marker, suggesting their potential role in early cognitive decline in PD patients [42]. This evidence concerns the gene APOA1 and Parkinson disease.